CIMPLRX
Latest round
- Series A
Last raised
- Jun 2020
Total raised
- $4.2M
Investors
- 3
About CIMPLRX
Founded in 2017 and headquartered in Anyang, South Korea, CIMPLRX operates in the biotechnology sector, specializing in innovative solutions for drug discovery.CIMPLRX specializes in drug discovery and development through its proprietary Explainable Artificial Intelligence (XAI) platform, CEEK-CURE. This platform consists of two main components: Create ExplainablE Knowledge (CEEK), which provides a user interface for data analysis, and Collect and Uncover RElationships (CURE), which processes various user requests on the server side. The platform uses Uniprot IDs to identify compounds related to biological targets, enabling the creation of predictive models that assist pharmaceutical companies and biotech firms in designing drug candidates and screening commercial databases.CIMPLRX's revenue model primarily relies on collaborations with pharmaceutical and biotechnology companies, typically involving project-based agreements for drug discovery initiatives. The company engages in direct B2B transactions, offering its CEEK-CURE platform as a service. These partnerships allow clients access to advanced predictive models and tools that optimize drug development.Looking ahead, CIMPLRX aims to enhance its CEEK-CURE platform with new features and predictive models tailored for drug discovery, although specific launch dates for these developments have not been announced. The company is also planning to expand its presence in European markets by 2023.
Who invested in CIMPLRX
3 investors across 1 round
See all investors in CIMPLRX
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 30, 2020
Amount
$4.2M
Investors
Questions about CIMPLRX
Who invested in CIMPLRX?
CIMPLRX has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CIMPLRX raised?
CIMPLRX has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did CIMPLRX last raise money?
CIMPLRX's most recent round on record is a Series A, in Jun 2020.
What does CIMPLRX do?
Founded in 2017 and headquartered in Anyang, South Korea, CIMPLRX operates in the biotechnology sector, specializing in innovative solutions for drug discovery.
Where is CIMPLRX headquartered?
CIMPLRX is headquartered in Anyang-si, South Korea.
Which VCs invest in companies like CIMPLRX?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at CIMPLRX's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like CIMPLRX? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.